Literature DB >> 8968045

Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.

T Grombacher1, S Mitra, B Kaina.   

Abstract

Repair of alkylated bases in DNA is performed by O6-methylguanine-DNA methyltransferase (MGMT) and a set of enzymes of the base excision repair pathway involving N-methylpurine-DNA glycosylase (MPG), apurinic endonuclease (APE), DNA polymerase beta (Pol beta) and DNA ligase. The level of expression of these enzymes may exert a profound effect on resistance of cells towards alkylating drugs. We have comparatively analyzed the expression of MGMT and the different base excision repair genes in rat hepatoma cells (line H4IIE) after exposure to alkylating agents, X-rays and the glucocorticoid hormone dexamethasone. Furthermore, the effect of these agents on the activity of the cloned human MGMT promoter was assayed. Exposure of cells to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or ionizing radiation increased MGMT mRNA levels up to 4.5-fold. Under the same conditions of treatment, exerting only a weak toxic effect, MPG and DNA ligase I mRNA levels were not enhanced, whereas the amounts of APE and Pol beta mRNA transiently increased by approximately 2-fold after X-ray and MNNG treatment, respectively. Dexamethasone induced both MGMT, APE and Pol beta mRNA and the induction paralleled the increase in mRNA of the glucocorticoid-dependent gene tyrosine aminotransferase. The observed increase in MGMT mRNA was due to promoter activation, which was shown in transient transfection assays with MGMT promoter-CAT reporter constructs in H4IIE cells. In these assays, the human MGMT promoter was found to be induced by methylating agents (MNNG and methyl methanesulfonate), ionizing radiation and dexamethasone. Weak induction of the promoter was observed after UV irradiation. Treatment with the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate was ineffective in promoter activation. The transfected MGMT promoter was not inducible by mutagens in HeLa S3 cells, which do not respond with induction of the endogenous MGMT gene. This is the first report showing hormone induction of a DNA repair gene (MGMT). The induction of MGMT and other genes encoding enzymes involved in DNA alkylation damage repair may be relevant in cancer therapy by causing resistance of tumor cells to alkylating drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968045     DOI: 10.1093/carcin/17.11.2329

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

1.  Abortive base-excision repair of radiation-induced clustered DNA lesions in Escherichia coli.

Authors:  J O Blaisdell; S S Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

2.  Effect of O6-methylguanine-DNA methyltransferase methylation in medulloblastoma.

Authors:  Tomoko Kurimoto; Akihide Kondo; Ikuko Ogino; Junya Fujimura; Atsushi Arakawa; Hajime Arai; Toshiaki Shimizu
Journal:  Mol Clin Oncol       Date:  2017-09-29

3.  Oxidative stress-induced CREB upregulation promotes DNA damage repair prior to neuronal cell death protection.

Authors:  Nicolás Pregi; Laura María Belluscio; Bruno Gabriel Berardino; Daniela Susana Castillo; Eduardo Tomás Cánepa
Journal:  Mol Cell Biochem       Date:  2016-11-05       Impact factor: 3.396

4.  Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.

Authors:  Shuguang Leng; Guodong Wu; Leonard B Collins; Cynthia L Thomas; Carmen S Tellez; Andrew R Jauregui; Maria A Picchi; Xiequn Zhang; Daniel E Juri; Dhimant Desai; Shantu G Amin; Richard E Crowell; Christine A Stidley; Yushi Liu; James A Swenberg; Yong Lin; Marc G Wathelet; Frank D Gilliland; Steven A Belinsky
Journal:  Cancer Res       Date:  2015-07-16       Impact factor: 12.701

5.  Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.

Authors:  Shadi Lalezari; Arthur P Chou; Anh Tran; Orestes E Solis; Negar Khanlou; Weidong Chen; Sichen Li; Jose A Carrillo; Reshmi Chowdhury; Julia Selfridge; Desiree E Sanchez; Ryan W Wilson; Mira Zurayk; Jonathan Lalezari; Jerry J Lou; Laurel Ormiston; Karen Ancheta; Robert Hanna; Paul Miller; David Piccioni; Benjamin M Ellingson; Colin Buchanan; Paul S Mischel; Phioanh L Nghiemphu; Richard Green; He-Jing Wang; Whitney B Pope; Linda M Liau; Robert M Elashoff; Timothy F Cloughesy; William H Yong; Albert Lai
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

6.  Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts.

Authors:  Gaspar J Kitange; Brett L Carlson; Mark A Schroeder; Patrick T Grogan; Jeff D Lamont; Paul A Decker; Wenting Wu; C David James; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2008-10-24       Impact factor: 12.300

7.  Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma Cells.

Authors:  April C L Bostian; Leena Maddukuri; Megan R Reed; Tatsiana Savenka; Jessica H Hartman; Lauren Davis; Dakota L Pouncey; Grover P Miller; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2015-12-30       Impact factor: 3.739

8.  Influence of Helicobacter pylori infection on the expression of MLH1 and MGMT in patients with chronic gastritis and gastric cancer.

Authors:  W Bartchewsky; M R Martini; A C Squassoni; M C Alvarez; M S P Ladeira; D M F Salvatore; M A Trevisan; J Pedrazzoli; M L Ribeiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-12-17       Impact factor: 3.267

9.  Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.

Authors:  Lucie Karayan-Tapon; Véronique Quillien; Joëlle Guilhot; Michel Wager; Gaëlle Fromont; Stephan Saikali; Amandine Etcheverry; Abderrahmane Hamlat; Delphine Loussouarn; Loïc Campion; Mario Campone; François-Marie Vallette; Catherine Gratas-Rabbia-Ré
Journal:  J Neurooncol       Date:  2009-10-20       Impact factor: 4.130

10.  Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.

Authors:  Barbara Ingold; Peter Schraml; Frank L Heppner; Holger Moch
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.